Search press releases
Every release here is real and links to its original. Filter by company, topic, language and date.
- Sands China Ltd.Sands China Joins Hands with NBA Legend to Distribute Boxed Lunches to the Macao CommunityAppreciation plaque unveiled at Fuhong Society of Macau's Happy Kitchen Social Enterprise Extending company's commitment to serving community through Impact Week — Coinciding with World Mental Health Day, Sands China and NBA Cares co-organised Health and...
- Corza Medical Launches Expanded Blink Single-Use Custom Packs and First-of-Its-Kind Microsurgical Knife Manufacturing ProcessCorza Medical, a leading global medical technology company, today announced the launch of its expanded Blink Single-Use Custom Packs offering and a first-of-its-kind automated manufacturing process for Sharpoint® microsurgical knives at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting taking place October 10 - 12 in New Orleans.
- LB Pharmaceuticals Presents New Preclinical Data Supporting LB-102’s Bimodal Mechanism of Action and Highlights Ongoing Late-Stage Clinical Development Programs at the 39th ECNP CongressLB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that address the multiple dimensions of underserved brain disorders, today announced the presentation of four posters at the 39th European College of Neuropsychopharmacology (ECNP) Congress, taking place in Munich, Germany from October 10-13, 2026. The posters highlight new preclinical data describing LB-102’s differentiated mechanism of action, the pivotal program of LB-102 in schizophrenia (NOVA-2 and NOVA-3), the ongoing late-stage development of LB-102 in bipolar depression (ILLUMINATE-1), and a previously reported analysis of LB-102’s impact on cognitive performance from the Phase 2 NOVA-1 trial in schizophrenia.
- vTv Therapeutics Inc.vTv Therapeutics Announces Oral Presentation at Breakthrough T1D Clinical and Research Congress 2026New research spotlights hypoglycemia-related burdens in adults with type 1 diabetes using automated insulin delivery systems
- Ninenovo; RingConnRingConn Receives FDA 510(k) Clearance for Non-Invasive Blood Oxygen (SpO2) MeasurementShenzhen Ninenovo Technology Limited, the parent company of RingConn, announced that its Smart Ring has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for non-invasive blood oxygen (SpO2) measurement (Clearance No....
- Akeso, Inc.First Patient Dosed in Phase III Perioperative Study of Cadonilimab (PD-1/CTLA-4) in Colon CancerAkeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a Phase III clinical study (COMPASSION-40/AK104-313) evaluating cadonilimab, its first-in-class PD-1/CTLA-4 bispecific antibody, as monotherapy in...
- The Rosen Law Firm PAROSEN, LEADING INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMSWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Hims & Hers Health, Inc. (NYSE: HIMS) between August 4, 2025 and July 29, 2026, both dates inclusive (the "Class Period"), of the important November 2, 2026 lead plaintiff deadline.SO WHAT: If you purchased Hims securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a...
- Kahn Swick & Foti, LLCHims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until November 2, 2026 to file lead plaintiff applications in a...
- Kahn Swick & Foti, LLCCVS Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CVS Health Corporation - CVSFormer Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into CVS Health Corporation ("CVS" or the "Company") (NYSE: CVS). On...
- Next Gen DiagnosticsThe Joint Commission has Recognized Genomic Surveillance for the Detection of Transmission in HospitalsHonors pioneering work at Presbyterian Hospital in Pittsburgh led by members of NGD Infection Prevention's Scientific Advisory Board — NGD Infection Prevention (NGD) today congratulates UPMC Presbyterian Hospital on receiving the Joint...
- SueWallSt.comAlignment Healthcare Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Alignment Healthcare (ALHC)Two Wall Street downgrades followed CMS's 3.5-star 2027 rating for the Alignment Healthcare contract covering more than 75% of its health-plan members. ALHC opened to a roughly 20% decline, and an investigation into potential securities law violations is underway. NEW YORK, Oct. 9, 2026...
- Hims & Hers Health (NYSE: HIMS) Faces Securities Fraud Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower - HBSSInvestors who lost money in HIMS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.